Clinical trials
Terminated Phase 1 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 9 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 5 |
| 2021 | 4 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute for Neurodegenerative Disorders | 9 |
| H. Lundbeck A/S | 4 |
| AbbVie | 2 |
| AstraZeneca | 2 |
| Avid Radiopharmaceuticals | 2 |
| GlaxoSmithKline | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Samus Therapeutics, Inc. | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Alzeca Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 52 |
| Cognitive Dysfunction | 5 |
| Dementia | 4 |
| Brain Diseases | 2 |
| Cognition Disorders | 2 |
| Multiple Sclerosis | 2 |
| Neurocognitive Disorders | 2 |
| Neurodegenerative Diseases | 2 |
| Parkinson Disease | 2 |
| Central Nervous System Diseases | 1 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.